Literature DB >> 21796068

Osteomalacia caused by skull base tumors: report of 2 cases.

Takeshi Uno1, Kensuke Kawai, Naoto Kunii, Seiji Fukumoto, Junji Shibahara, Toru Motoi, Nobuhito Saito.   

Abstract

BACKGROUND AND IMPORTANCE: Tumor-induced osteomalacia (TIO) is an uncommon paraneoplastic syndrome rarely encountered in neurosurgical practice. We report on 2 cases of TIO caused by skull base tumors. Although the diagnosis of TIO is difficult to make and often is delayed because of the insidious nature of the symptoms, mostly systemic pain and weakness, it is curable once it is diagnosed and properly treated. CLINICAL
PRESENTATION: Both patients presented with severe pain developing in the lower extremities and moving out to the entire body, as well as difficulty moving. They were diagnosed with TIO several years after onset. A high level of serum FGF23 was confirmed, and whole-body imaging studies demonstrated tumors in the middle and anterior cranial base, respectively. The patient with the anterior cranial base tumor had a history of hemorrhage into the frontal lobe and partial resection. En bloc resection of tumor with surrounding skull bone was performed. The histological diagnosis for both cases was phosphaturic mesenchymal tumor, mixed connective tissue variant.
CONCLUSION: The level of FGF23 normalized immediately after surgery. Both patients experienced a dramatic relief of pain and recovery of muscle power. Although reports of osteomalacia caused by tumors in the neurosurgical field are extremely rare in the literature, its true incidence is unknown. We emphasize the importance of recognition of this syndrome and recommend total resection of tumors when possible.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796068     DOI: 10.1227/NEU.0b013e31821867f7

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

Review 1.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

2.  Malignant phosphaturic mesenchymal tumor of the pelvis: A report of two cases.

Authors:  Tokimitsu Morimoto; Satoshi Takenaka; Nobuyuki Hashimoto; Nobuhito Araki; Akira Myoui; Hideki Yoshikawa
Journal:  Oncol Lett       Date:  2014-04-22       Impact factor: 2.967

3.  Tumor-induced Osteomalacia Caused by a Parotid Tumor.

Authors:  Yuichi Takashi; Yuka Kinoshita; Nobuaki Ito; Manabu Taguchi; Masaaki Takahashi; Naoya Egami; Shogo Tajima; Masaomi Nangaku; Seiji Fukumoto
Journal:  Intern Med       Date:  2017-03-01       Impact factor: 1.271

Review 4.  Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.

Authors:  Huanwen Wu; Marilyn M Bui; Lian Zhou; Dongmei Li; Hui Zhang; Dingrong Zhong
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

5.  Selective blood sampling for FGF-23 in tumor-induced osteomalacia.

Authors:  Hans-Christof Schober; Christian Kneitz; Franziska Fieber; Kathrin Hesse; Henry Schroeder
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-10-06

6.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.